Brain Monitoring

Connecting cardiological and neurological health: Key neurotech patent by Medtronic

by

cardiac signals
– Illus­tra­tive image from U.S. Patent No. 8,209,009

Today we are shar­ing a fas­ci­nat­ing Medtron­ic patent com­bin­ing car­diac mon­i­tor­ing with brain stim­u­la­tion. (As men­tioned, we are fea­tur­ing foun­da­tion­al Per­va­sive Neu­rotech patents, from old­er to new­er by issue date)

U.S. Patent No. 8,209,009: Sys­tem and method for seg­ment­ing a car­diac sig­nal based on brain stimulation

  • Assignee(s): Medtron­ic, Inc.
  • Inventor(s): Jonathon E. Gif­takis, Nina M. Graves, Mark Turn­er Rise
  • Tech­nol­o­gy Cat­e­go­ry: Neuro-monitoring
  • Issue Date: June 26, 2012

SharpBrains’ Take:

This patent con­sid­ers the inter-rela­tion­ship and co-occur­rence of activ­i­ty between brain and heart. [Read more…] about Con­nect­ing car­di­o­log­i­cal and neu­ro­log­i­cal health: Key neu­rotech patent by Medtronic

Fully concentrated on task at hand? Then your computer won’t distract you

by

brain notification
Illus­tra­tive image from U.S. Patent No. 8,055,722

—

Today we high­light a fas­ci­nat­ing patent by IBM that lever­ages brain mon­i­tor­ing (includ­ing EEG feed­back) to sup­press dis­tract­ing notifications–hopefully such a sys­tem will become avail­able soon!  [Read more…] about Ful­ly con­cen­trat­ed on task at hand? Then your com­put­er won’t dis­tract you

The future of EEG-based personal devices monitoring brain function: Key neurotechnology patent #26

by

medical communication device
– Illus­tra­tive image from U.S. Patent No. 7,138,902

Today we high­light a very inter­est­ing 2006 patent assigned to Phillips and Accen­ture — who have been col­lab­o­rat­ing  to devel­op soft­ware for EEG-based oper­a­tion of home appli­ances to aid patients suf­fer­ing from neu­ro­gen­er­a­tive dis­eases such as ALS (amy­otroph­ic lat­er­al sclerosis).

U.S. Patent No. 7,138,902: Per­son­al med­ical com­mu­ni­ca­tion device and system

  • Assignee(s): Phillips, Accenture
  • Inventor(s): Ray­mond J. Menard
  • Tech­nol­o­gy Cat­e­go­ry: EEG
  • Issue Date: Novem­ber 21, 2006

SharpBrains’ Take:

The ‘902 patent relates to tech­niques and sys­tems for per­son­al med­ical devices, evi­denc­ing the trend (as described in Back­ground of the Spec­i­fi­ca­tion) of the expan­sion of med­ical ser­vice deliv­ery from strict­ly with­in med­ical cen­ters into the homes and/or mobile lifestyles of patients. [Read more…] about The future of EEG-based per­son­al devices mon­i­tor­ing brain func­tion: Key neu­rotech­nol­o­gy patent #26

Medical signal monitoring and display: Key Neurotech Patent #3

by

medial-signal-monitoring and display
– Illus­tra­tive image from U.S. Patent No. 6,224,549

Today we are shar­ing a 2001 patent assigned to Care­fu­sion 209, Inc. (As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date)

U.S. Patent No. 6,224,549: Med­ical sig­nal mon­i­tor­ing and display

  • Assignee(s): Care­fu­sion 209, Inc.
  • Inventor(s): Wirm van Drongelen
  • Tech­nol­o­gy Cat­e­go­ry: EEG
  • Issue Date: May 1, 2001

SharpBrains’ Take:

The ‘549 patent address­es this prob­lem by com­bin­ing EEG data with oth­er sen­sor data (e.g., EMG data), togeth­er with a cus­tomiz­able pre­sen­ta­tion that is best suit­ed for the nurse, doc­tor or patient gath­er­ing data.

[Read more…] about Med­ical sig­nal mon­i­tor­ing and dis­play: Key Neu­rotech Patent #3

Witnessing an explosion of consumer-facing neurotechnologies to (potentially) harness lifelong neuroplasticity

by

—

Last week I shared some key sci­en­tif­ic, tech­no­log­i­cal and invest­ment trends rev­o­lu­tion­iz­ing Brain Health, based on my par­tic­i­pa­tion at the 2016 Sharp­Brains Vir­tu­al Sum­mit, and promised a sec­ond arti­cle more focused on the tech­nol­o­gy side of things.

Here it is 🙂

Just a few weeks after the Sharp­Brains Sum­mit I also attend­ed CES 2017. While I enjoyed the myr­i­ad emerg­ing tech­nolo­gies –autonomous vehi­cles, robot­ics, drones, aug­ment­ed and vir­tu­al real­i­ty head­sets, voice acti­vat­ed every­thing– I was most­ly struck by a firm named Halo Neu­ro­science. They have a fas­ci­nat­ing wear­able prod­uct, Halo Sport, claim­ing to accel­er­ate gains in strength, explo­sive­ness, endurance, and mus­cle mem­o­ry, improv­ing the brain’s response to ath­let­ic train­ing. It uses tDCS (tran­scra­nial direct cur­rent stim­u­la­tion), essen­tial­ly prim­ing move­ment-relat­ed cir­cuits of the brain to become more recep­tive to stim­uli, help­ing the brain wire in the prac­tice for improved future response.

The cutting edge of applied neuroplasticity

Both con­fer­ences allowed me to see the cut­ting edge of [Read more…] about Wit­ness­ing an explo­sion of con­sumer-fac­ing neu­rotech­nolo­gies to (poten­tial­ly) har­ness life­long neuroplasticity

News: Advanced Brain Monitoring receives Global Health and Pharma Award for clinical-grade platforms monitoring brain’s electrical activity

by

—

Advanced Brain Mon­i­tor­ing Named “Most Inno­v­a­tive Med­ical Device Com­pa­ny” at Glob­al Health and Phar­ma Awards (Sleep Review):

“Advanced Brain Mon­i­tor­ing Inc was named the “Most Inno­v­a­tive Med­ical Device Com­pa­ny” by Glob­al Health and Phar­ma at its 2016 Health­care and Phar­ma­ceu­ti­cal awards. “This award rec­og­nizes our company’s suc­cess­es in devel­op­ing tech­nolo­gies which enable clin­i­cians and clin­i­cal tri­al spon­sors to pro­file brain health through the analy­sis of the brain’s elec­tri­cal activ­i­ty (EEG) dur­ing sleep and wake,” says Chris Berka, Advanced Brain Mon­i­tor­ing CEO…The com­pa­ny was recent­ly award­ed a $1.5 mm grant from Nation­al Insti­tute of Health to expand its data­base of awake and sleep EEG in patients with neu­rode­gen­er­a­tive dis­eases. “The envi­sioned future is for rou­tine brain health assess­ments dur­ing sleep and wak­ing to be con­duct­ed in a man­ner sim­i­lar to a mam­mo­gram or colonoscopy,” says Berka. “Ulti­mate­ly, ear­ly detec­tion will increase the like­li­hood that an inter­ven­tion can be matched to the patient based on the pres­ence of brain bio­mark­ers and admin­is­tered pri­or to the onset of cog­ni­tive decline.”

To learn more: